SMCP (SMCP) AGM 2025 summary
Event summary combining transcript, slides, and related documents.
AGM 2025 summary
13 Jun, 2025Opening remarks and agenda
Quorum established and bureau constituted to commence the meeting.
Agenda included review of 2024 achievements, RSE progress, financial results, governance, auditor reports, Q&A, and voting on resolutions.
Financial performance review
2024 marked as a transition year with resilient sales and improved operational margin in H2.
Revenue reached €1,212M, with 1,662 points of sale and a gross margin of 74.4%.
EBIT at €51M, free cash flow at €49M, and net debt reduced to €237M.
Regional sales: France +1.1%, EMEA +3.1%, America +5.7%, Asia -17.7%.
Q1 2025 sales at €297M, up 2.6% organically, with a maintained full-price strategy.
Board and executive committee updates
Board has 67% independence and 56% women, with an average age of 58 and four nationalities.
Board met six times with 95% attendance; committees (Audit, Nominations, RSE) met 2-3 times each.
Renewal of mandates proposed for key executives, covering a broad range of expertise.
Latest events from SMCP
- Record profitability, free cash flow, and margin gains in 2025, with 2026 guidance reaffirmed.SMCP
H2 202526 Feb 2026 - Sales fell 3.6% to €585m, margin up to 74.3%, China weak, outlook cautious but cost actions ongoing.SMCP
H1 20242 Feb 2026 - Sales fell 2.7% organically as China lagged, but Europe and America remained resilient.SMCP
Q3 2024 TU18 Jan 2026 - Resilient sales and strong cash flow set up margin recovery and €50m FCF by 2026.SMCP
H2 20247 Jan 2026 - Q1 2025 sales up 3.4% to €297m, gross margin rises, outlook cautious amid global uncertainties.SMCP
Q1 2025 TU27 Dec 2025 - 9M sales up 2.8% organically to €896m, led by EMEA and America, with APAC declining.SMCP
Q3 2025 TU13 Dec 2025 - Adjusted EBIT margin more than doubled and net income turned positive on strong H1 2025 results.SMCP
H1 202516 Nov 2025